203 related articles for article (PubMed ID: 12864985)
1. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
Dhib-Jalbut S; Chen M; Said A; Zhan M; Johnson KP; Martin R
J Neuroimmunol; 2003 Jul; 140(1-2):163-71. PubMed ID: 12864985
[TBL] [Abstract][Full Text] [Related]
2. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS.
Chen M; Gran B; Costello K; Johnson K; Martin R; Dhib-Jalbut S
Mult Scler; 2001 Aug; 7(4):209-19. PubMed ID: 11548979
[TBL] [Abstract][Full Text] [Related]
3. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
Jansson A; Ernerudh J; Kvarnström M; Ekerfelt C; Vrethem M
Mult Scler; 2003 Oct; 9(5):440-5. PubMed ID: 14582766
[TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.
Ziemssen T; Kümpfel T; Klinkert WE; Neuhaus O; Hohlfeld R
Brain; 2002 Nov; 125(Pt 11):2381-91. PubMed ID: 12390966
[TBL] [Abstract][Full Text] [Related]
5. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Duda PW; Schmied MC; Cook SL; Krieger JI; Hafler DA
J Clin Invest; 2000 Apr; 105(7):967-76. PubMed ID: 10749576
[TBL] [Abstract][Full Text] [Related]
6. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
[TBL] [Abstract][Full Text] [Related]
7. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
8. Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6 years.
Chen M; Conway K; Johnson KP; Martin R; Dhib-Jalbut S
J Neurol Sci; 2002 Sep; 201(1-2):71-7. PubMed ID: 12163197
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.
Moldovan IR; Cotleur AC; Zamor N; Butler RS; Pelfrey CM
J Neuroimmunol; 2008 Jan; 193(1-2):161-9. PubMed ID: 18022700
[TBL] [Abstract][Full Text] [Related]
10. Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients.
Qin Y; Zhang DQ; Prat A; Pouly S; Antel J
J Neuroimmunol; 2000 Aug; 108(1-2):201-6. PubMed ID: 10900354
[TBL] [Abstract][Full Text] [Related]
11. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
12. Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy.
Ziemssen T; Kümpfel T; Schneider H; Klinkert WE; Neuhaus O; Hohlfeld R
J Neurol Sci; 2005 Jun; 233(1-2):109-12. PubMed ID: 15869765
[TBL] [Abstract][Full Text] [Related]
13. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
[TBL] [Abstract][Full Text] [Related]
14. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis.
Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
Eur J Immunol; 1998 Oct; 28(10):3329-35. PubMed ID: 9808202
[TBL] [Abstract][Full Text] [Related]
15. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1.
Aharoni R; Teitelbaum D; Sela M; Arnon R
J Neuroimmunol; 1998 Nov; 91(1-2):135-46. PubMed ID: 9846830
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.
Dhib-Jalbut S; Chen M; Henschel K; Ford D; Costello K; Panitch H
Mult Scler; 2002 Dec; 8(6):485-91. PubMed ID: 12474988
[TBL] [Abstract][Full Text] [Related]
17. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production.
Pelfrey CM; Rudick RA; Cotleur AC; Lee JC; Tary-Lehmann M; Lehmann PV
J Immunol; 2000 Aug; 165(3):1641-51. PubMed ID: 10903775
[TBL] [Abstract][Full Text] [Related]
18. TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
Oreja-Guevara C; Ramos-Cejudo J; Aroeira LS; Chamorro B; Diez-Tejedor E
BMC Neurol; 2012 Sep; 12():95. PubMed ID: 22989378
[TBL] [Abstract][Full Text] [Related]
19. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
[TBL] [Abstract][Full Text] [Related]
20. Human and murine CD4 T cell reactivity to a complex antigen: recognition of the synthetic random polypeptide glatiramer acetate.
Duda PW; Krieger JI; Schmied MC; Balentine C; Hafler DA
J Immunol; 2000 Dec; 165(12):7300-7. PubMed ID: 11120865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
